Prevention & Chronic Conditions

About

Cardiovascular disease (CVD) is a significant and ever-growing problem in the UK, accounting for nearly one-third of all deaths and leading to significant morbidity. Globally CVD accounts for 31% of mortality, mainly from heart disease and cerebrovascular accident.

The burden of CVD can be ameliorated by careful risk modification and primary prevention is an important priority for all developers of health policy. Strong consensus exists between international guidelines regarding the necessity of smoking cessation, weight optimisation and exercise, although guidelines have slightly different approaches to hypertension and vary considerably regarding their approach to optimal lipid profile, which remains a contentious issue.

Articles

Cardiovascular Risk Management Targeting Inflammation in Addition to Lipid-lowering Therapy

Citation:

European Cardiology Review 2017;12(2):88

Management of Complications in Anticoagulated Patients with Atrial Fibrillation

Citation:

Arrhythmia & Electrophysiology Review 2017;6(4):167–78.

Proprotein Convertase Subtilisin/Kexin 9 (PCSK9) Inhibition in Patients With or at High Risk of Coronary Heart Disease

Citation:

US Cardiology Review 2017;11(1):16–7

Dyslipidemia: Current Therapies and Guidelines for Treatment

Citation:

US Cardiology Review 2017;11(1):10–5